rs199660276
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4
The NM_000540.3(RYR1):c.12599A>G(p.Asn4200Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N4200N) has been classified as Likely benign.
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457892Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 725158
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
RYR1-related disorder Uncertain:2
The RYR1 c.12599A>G variant is predicted to result in the amino acid substitution p.Asn4200Ser. This variant was reported in a patient with axial myopathy; however, this patient had additional variants in other candidate genes (Proband 2 in Clarke et al. 2013. PubMed ID: 23478172). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 4200 of the RYR1 protein (p.Asn4200Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with axial myopathy (PMID: 23478172). ClinVar contains an entry for this variant (Variation ID: 478174). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
Reported as heterozygous in an individual with axial myopathy, in whom a variant in the MYH7 gene was also detected and believed to be causative; a healthy parent was also heterozygous for the RYR1 variant (Clarke et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23478172) -
- -
Malignant hyperthermia, susceptibility to, 1 Uncertain:1
- -
Congenital myopathy with fiber type disproportion;C1840365:King Denborough syndrome;C1850674:Congenital multicore myopathy with external ophthalmoplegia;C2930980:Malignant hyperthermia, susceptibility to, 1;C5830701:Central core myopathy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at